Brief: Theravet End-June Available Cash Down At Eur 3.50 Million

Theravet SA

30/06/2022 16:53

June 30 (Reuters) - Theravet SA  ALVET.PA :
    * THERAVET PROVIDES ITS 2022 FIRST HALF-YEAR OPERATIONAL
UPDATE
    * AVAILABLE CASH ON JUNE 30, 2022, IS EUR 3.50 MILLION
COMPARED TO
EUR 7.25 MILLION ON JUNE 30, 2021
    * COMPANY'S TIGHT MANAGEMENT ALLOWS ITS CASH TO COVER 2
YEARS OF
OPERATIONAL ACTIVITIES
    * VISCO-VET DEVELOPMENT PLAN IS NOW EXPECTED TO SUFFER DELAY
OF
SEVERAL MONTHS AS COMPARED TO INITIAL DEVELOPMENT PLAN
    * COMPANY REMAINS CONFIDENT IN ITS ABILITY TO REACH ITS
OBJECTIVES
    * NUZOA WILL LEVERAGE ITS OWN SALES AND MARKETING FORCE IN
VETERINARY FIELD TO PROMOTE AND DISTRIBUTE BIOCERA-VET® PRODUCTS
IN SPAIN AS FROM SEPTEMBER 2022
    * VI WILL LEVERAGE ITS OWN SALES AND MARKETING STRIKE FORCE
IN
VETERINARY FIELD TO PROMOTE AND DISTRIBUTE BIOCERA-VET® PRODUCTS
IN UK & IRELAND AS FROM JUNE 2022
    * NEXT KEY COMPANY MILESTONE IS TO EXPAND COMMERCIALIZATION
OF
BIOCERA-VET® TO GERMANY

Source text for Eikon:  ID:nBw9zfj7Ya 
Further company coverage:  ALVET.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))